美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

TEMA ONCOLOGY ETF

41.65

-0.3620-0.86%

盤後：41.64-0.0125-0.03%16:10 EDT

成交量：1.85萬

成交額：77.26萬

市值：2.07億

市盈率：- -

高：42.15

開：42.15

低：41.43

收：42.01

52周最高：47.00

52周最低：26.62

股本：498.00萬

流通股本：498.00萬

量比：0.54

換手率：0.37%

股息：0.02

股息率：0.05%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

隨着生物技術行業勢頭持續，Retension Pharmaceuticals和TRex Bio相繼提交美國IPO申請

美國食品藥品監督管理局批准禮來公司的一款乳腺癌聯合用藥方案

美國FDA批准Inluriyo（Imlunestrant）聯合Verzenio（Abemaciclib）用於治療ER陽性、HER2陰性、ESR1突變的晚期或轉移性乳腺癌成人患者

羅氏（RHHBY）重磅藥Ocrevus獲CHMP積極意見擬在歐洲拓展兒科多發性硬化症適應症

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/CANC"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"CANC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CANC\",,,,,undefined,":{"symbol":"CANC","market":"US","secType":"STK","nameCN":"TEMA ONCOLOGY ETF","latestPrice":41.6525,"timestamp":1789761600000,"preClose":42.0145,"halted":0,"volume":18510,"hourTrading":{"tag":"盘后","latestPrice":41.64,"preClose":41.6525,"latestTime":"16:10 EDT","volume":9,"amount":374.295,"timestamp":1789762204471,"change":-0.0125,"changeRate":-0.0003,"amplitude":0},"delay":0,"changeRate":-0.008616073022408806,"floatShares":4980000,"shares":4980000,"eps":0,"marketStatus":"休市中","change":-0.362,"latestTime":"09-18 16:00:00 EDT","open":42.15,"high":42.15,"low":41.43,"amount":772614,"amplitude":0.017137,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"listingDate":1692158400000,"exchange":"NASDAQ","adjPreClose":42.0145,"sharesOutstanding":4310000,"nav":41.99,"aum":209110200,"dividendRate":0.000471,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":41.64,"preClose":41.6525,"latestTime":"16:10 EDT","volume":9,"amount":374.295,"timestamp":1789762204471,"change":-0.0125,"changeRate":-0.0003,"amplitude":0},"volumeRatio":0.540633688961473},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CANC\",,,,,undefined,":{"symbol":"CANC","floatShares":4980000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.540633688961473,"shares":4980000,"dividePrice":0.0196,"high":42.15,"amplitude":0.017137,"preClose":42.0145,"low":41.43,"week52Low":26.62,"pbRate":"--","week52High":47,"institutionHeld":0,"latestPrice":41.6525,"eps":0,"divideRate":0.000471,"volume":18510,"delay":0,"ttmEps":0,"open":42.15,"prevYearClose":34.7203,"prevWeekClose":41.5285,"prevMonthClose":43.3492,"prevQuarterClose":41.24,"fiveDayClose":41.5285,"twentyDayClose":44.0307,"sixtyDayClose":39.1725},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CANC\",params:#limit:5,,,undefined,":[{"date":"2025-12-10","symbol":"CANC","amount":0.0195905,"announcedDate":"2025-12-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-10","defaultRemindTime":1765377000000,"name":"TEMA ONCOLOGY ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-11","payableDate":"2025-12-10","currency":"USD","dateTimestamp":1765342800000,"payDate":"2025-12-11"},{"date":"2024-12-11","symbol":"CANC","amount":0.72827,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-11","defaultRemindTime":1733927400000,"name":"TEMA ONCOLOGY ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-12","payableDate":"2024-12-11","currency":"USD","dateTimestamp":1733893200000,"payDate":"2024-12-12"},{"date":"2023-12-13","symbol":"CANC","amount":0.149112,"announcedDate":"2023-12-12","type":"dividend","market":"US","newRecordDate":"2023-12-14","defaultRemindTime":1702477800000,"name":"TEMA ONCOLOGY ETF","recordDate":"2023-12-15","payableDate":"2023-12-14","currency":"USD","dateTimestamp":1702443600000,"payDate":"2023-12-15"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CANC\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-13","recordDate":"2023-12-14","paymentDate":"2023-12-15","value":0.149112,"currency":"USD"},{"executeDate":"2024-12-11","recordDate":"2024-12-11","paymentDate":"2024-12-12","value":0.72827,"currency":"USD"},{"executeDate":"2025-12-10","recordDate":"2025-12-10","paymentDate":"2025-12-11","value":0.0195905,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CANC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CANC\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2668597668","title":"隨着生物技術行業勢頭持續，Retension Pharmaceuticals和TRex Bio相繼提交美國IPO申請","url":"https://stock-news.laohu8.com/highlight/detail?id=2668597668","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668597668?lang=zh_tw&edition=fundamental","pubTime":"2026-09-19 06:35","pubTimestamp":1789770948,"startTime":"0","endTime":"0","summary":"更新版 1-随着生物技术行业势头持续，Retension Pharmaceuticals和TRex Bio相继提交美国IPO申请在第4、6-7段中补充了分析师评论路透9月18日-药物开发商Retension Pharmaceuticals和TRex Bio于上周五提交了在美国进行首次公开募股的申请文件，进一步充实了今年秋季IPO窗口期的生物技术项目储备。肯尼迪表示，鉴于Electra股价的下跌，生物科技公司的IPO将面临更严格的审查。Leerink Partners、古根海姆证券、奥本海默和Titan Partners是Retension此次发行的承销商。Retension和TRex将分别以股票代码“RTSN”和“TRXB”在纳斯达克上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nL4S45A1QQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0354030511.USD","LU0683600562.USD","LLII","LU1093756168.USD","LU2360106947.USD","LU2237443549.SGD","SGXZ31699556.SGD","LU2471134879.HKD","LU2491049909.HKD","LU1868837300.USD","MHIP","LU2237438978.USD","LU2471134952.CNY","IE00BFSS7M15.SGD","LU2168564495.EUR","SG9999018865.SGD","IE0002141913.USD","LU1023059063.AUD","LU2746668461.USD","SG9999001176.SGD","SG9999014914.USD","XLV","LU1720051017.SGD","LU0820562030.AUD","LU2462157665.USD","LU0456855351.SGD","LU0640476718.USD","LU1145028129.USD","LU0289739699.SGD","LU1323610961.USD","FTXH","IE00B2B36J28.USD","BK4599","BK4534","LU0417517546.SGD","LU1974910355.USD","WDNA","LU2471134523.USD","LU0353189763.USD","LU0225283273.USD","THNR","IE00BJJMRZ35.SGD","LU2237443622.USD","LU1720051108.HKD","LU0823434583.USD","IE00BKDWB100.SGD","IYH","LU0133085943.USD","LU2112291526.USD","LU2746668974.SGD","SG9999014898.SGD","FHLC","LU1093756325.SGD","LU2089984988.USD","LU0964807845.USD","LU0786609619.USD","IE00B4JS1V06.HKD","IE00BJT1NW94.SGD","SGXZ81514606.USD","LU2168564065.EUR","IE00BJLML261.HKD","PJP","LU2324357040.USD","SG9999013999.USD","BK4007","LU0820561818.USD","LU1057294990.SGD","TMED","LU0210536198.USD","LU2211815571.USD","LU2461242641.AUD","LU0354030438.USD","LU1917777945.USD","LU1988902786.USD","LU0320765992.SGD","LU2087625088.SGD","LU2168563687.JPY","IE00B775H168.HKD","LU0266013472.USD","LU2271345857.HKD","LU2756315318.SGD","SG9999014906.USD","LU0006306889.USD","SG9999015986.USD","IE00BFSS8Q28.SGD","IE00B1BXHZ80.USD","LLYX","LU0097036916.USD","LU0708995401.HKD","LU2168564222.USD","LU0109391861.USD","LU2750360997.AUD","LU2756315664.SGD","ILDR","LU0203201768.USD","LU0234572021.USD","LU1366192091.USD","LU1989771016.USD","BK4585","LU1127390331.HKD","MEDX","SGXZ57979304.SGD","LU2237443465.HKD","LU0061475181.USD","LU2108987350.USD","LU2237443382.USD","LU0320765059.SGD","LU0689472784.USD","LU0882574055.USD","LU2028103732.USD","ELIL","IE00B7KXQ091.USD","IXJ","LU0122379950.USD","LU2417539215.USD","SG9999017495.SGD","LU2023251221.USD","LU2111349929.HKD","LU0174119429.USD","LU0094547139.USD","LU0203202063.USD","LU1064131342.USD","LU1623119135.USD","LU1035775433.USD","LU1712237335.SGD","LU2265009873.SGD","IHE","LU2456880835.USD","LLY","LU1551013342.USD","LU2462591350.SGD","LU2552382132.HKD","SG9999014880.SGD","LU1061106388.HKD","SG9999015952.SGD","LU2361045086.USD","TRUH","LU0106261372.USD","GB00BDT5M118.USD","LU0882574139.USD","LU1267930730.SGD","LU0823434740.USD","AGNG","IE0001KFT4U8.USD","IE00BN29S564.USD","LU1868837136.USD","LU0158827948.USD","LU2552382058.USD","LU1548497426.USD","LU0672654240.SGD","MEDI","IE0005OL40V9.USD","LU0345770993.USD","LU2471134796.USD","IE00BK4W5M84.HKD","LU1629891620.HKD","LU2357305700.SGD","LU2023250330.USD","LU0432979614.USD","TREX","LU0238689110.USD","LU0256863902.USD","LU0943347566.SGD","LU2750360641.GBP","LU0079474960.USD","IE0009355771.USD","IE00BJJMRX11.SGD","ETRA","LU0109394709.USD","CANC","LU0114720955.EUR","ELIS","IE00BWXC8680.SGD","IE00B4R5TH58.HKD","LU0096364046.USD","IE00BFTCPJ56.SGD","LU2491050071.SGD","LU0323591593.USD","OZEM","LU0256863811.USD","BK4086","LU1814569148.SGD","SG9999015978.USD","LU1551013425.SGD","LU0316494557.USD","LU1804176565.USD","BK4588","IE00BKPKM429.USD","LU0889565916.HKD","LU2168564149.EUR","LU2089283258.USD","LU2468319806.SGD","LU1868836757.USD","IE0004445015.USD","LU2089284900.SGD","LU2491050154.USD","BK4581","HRTS","SG9999018857.SGD","LU0787776722.HKD","SG9999001176.USD","LU2896262040.SGD","CURE","IE00BK4W5L77.USD","LU2264538146.SGD","LU1069344957.HKD","LU2602419157.SGD","LU0353189680.USD","SG9999015945.SGD","LU2023250504.SGD","LU1280957306.USD","LU2361044865.SGD","SGXZ51526630.SGD","LU0385154629.USD","LU0466842654.USD","RXL","VHT","LU2213496289.HKD","LU2236285917.USD","LU1868836591.USD","LU0471298694.HKD","LLYZ","LU2237443978.SGD","LU1868836914.USD","LU1291159041.SGD","LU0345770308.USD","BK4533","LU0471298777.SGD","LU0158827781.USD","LU1691799644.USD","LU0198837287.USD","LU0823416689.USD","LU0058720904.USD","IE0004445239.USD","LU2063271972.USD","BK4516","LU0820561909.HKD","LU2237443895.HKD","LU2552382215.SGD","SGXZ99366536.SGD","GDOC","JDOC","LU1232071149.USD","LU1979441026.SGD","LU2361044949.HKD","PPH","IE00B1XK9C88.USD","LU2106854487.HKD","IE00BJJMRY28.SGD","LU1983299246.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668592075","title":"美國食品藥品監督管理局批准禮來公司的一款乳腺癌聯合用藥方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2668592075","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668592075?lang=zh_tw&edition=fundamental","pubTime":"2026-09-19 03:11","pubTimestamp":1789758678,"startTime":"0","endTime":"0","summary":"礼来公司表示，约一半的雌激素受体阳性、HER2阴性转移性乳腺癌患者在接受一种广泛使用的激素阻断疗法治疗期间或之后会出现ESR1突变。美国食品药品监督管理局已于去年9月批准  的Inluriyo用于治疗转移性乳腺癌，即携带ESR1突变的IV期乳腺癌。该批准基于一项针对159名此类晚期乳腺癌患者的晚期临床研究。礼来公司表示，Inluriyo与Verzenio的联合用药方案即日起在美国上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nL4S45A1I7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","LU1988902786.USD","LU2237443978.SGD","IE0002141913.USD","IE0009355771.USD","SG9999014914.USD","LU2491050154.USD","LU0943347566.SGD","BK4599","IE00B4R5TH58.HKD","HRTS","LU0079474960.USD","LU1551013425.SGD","LU2360106947.USD","LU1551013342.USD","LU0823434740.USD","LU2168563687.JPY","SG9999015978.USD","BK4533","IE00B1XK9C88.USD","LU2357305700.SGD","LU2756315318.SGD","LU1979441026.SGD","LU1720051017.SGD","IE00BKDWB100.SGD","LU2237438978.USD","LU0432979614.USD","IYH","LU0466842654.USD","IE0001KFT4U8.USD","LU2237443549.SGD","LU2896262040.SGD","SGXZ31699556.SGD","LU0096364046.USD","LU1023059063.AUD","LU2361045086.USD","WDNA","LU1280957306.USD","LU1712237335.SGD","LU2750360641.GBP","LU1868836914.USD","LU0889565916.HKD","IHE","LU0787776722.HKD","LU0456855351.SGD","LU2491050071.SGD","SG9999014898.SGD","IE0005OL40V9.USD","SGXZ51526630.SGD","LU2089283258.USD","LU2211815571.USD","LU2461242641.AUD","LU2746668974.SGD","LU0385154629.USD","LU2089984988.USD","LU0354030511.USD","LU1629891620.HKD","LU2361044949.HKD","LU0174119429.USD","LU2471134796.USD","ILDR","IE00B775H168.HKD","LU0289739699.SGD","LU0109391861.USD","LLYZ","LU0683600562.USD","LU2361044865.SGD","LU1720051108.HKD","LU1989771016.USD","LU0689472784.USD","LU2112291526.USD","THNR","LU2168564222.USD","LU1057294990.SGD","LU1093756168.USD","LU0471298694.HKD","LU1323610961.USD","SGXZ99366536.SGD","IE00BJJMRY28.SGD","MHIP","LU2106854487.HKD","BK4007","LU0094547139.USD","LU0964807845.USD","SG9999015986.USD","LU1267930730.SGD","LU1974910355.USD","LU2237443382.USD","LU2417539215.USD","VHT","LU2750360997.AUD","IE00B4JS1V06.HKD","LU0203201768.USD","LU2491049909.HKD","LU1868837300.USD","LU0198837287.USD","LU1093756325.SGD","MEDI","LU0109394709.USD","TRUH","LU0158827948.USD","LU2264538146.SGD","LU0786609619.USD","LU0256863902.USD","LU1868836757.USD","LU2108987350.USD","FTXH","LU0256863811.USD","LU2552382132.HKD","IE00B1BXHZ80.USD","LU0133085943.USD","LU0882574055.USD","IE00BN29S564.USD","LLII","MEDX","SG9999018857.SGD","IE00BKPKM429.USD","ELIS","LU0097036916.USD","LU2023250504.SGD","LU0266013472.USD","LU2237443622.USD","LU1061106388.HKD","LU2237443895.HKD","RXL","LU1804176565.USD","LU0823416689.USD","LU2471134952.CNY","LU1917777945.USD","JDOC","CURE","IE0004445239.USD","LU1814569148.SGD","LU0820561818.USD","LU2552382058.USD","TMED","XLV","IE00BFSS7M15.SGD","BK4585","LU0238689110.USD","LLYX","GB00BDT5M118.USD","LU0316494557.USD","LU2111349929.HKD","LU2462591350.SGD","LU0203202063.USD","LU1691799644.USD","GDOC","LU2168564149.EUR","LU0210536198.USD","LU0820562030.AUD","LU2089284900.SGD","SG9999018865.SGD","SG9999014906.USD","LU1232071149.USD","LU2756315664.SGD","LU2213496289.HKD","PPH","LU2324357040.USD","LU2456880835.USD","IE00BK4W5M84.HKD","SG9999017495.SGD","LU0106261372.USD","LU0225283273.USD","LU1127390331.HKD","FHLC","SG9999013999.USD","LU1064131342.USD","LU2746668461.USD","ELIL","LU2028103732.USD","LU1035775433.USD","BK4588","IE0004445015.USD","IE00BFSS8Q28.SGD","LU1366192091.USD","LU1291159041.SGD","AGNG","LU2602419157.SGD","LU0354030438.USD","LU0417517546.SGD","LU2168564065.EUR","SG9999014880.SGD","LU0708995401.HKD","LU0122379950.USD","LLY","LU1868836591.USD","LU2471134879.HKD","IE00BJLML261.HKD","IE00B7KXQ091.USD","LU2023250330.USD","LU2265009873.SGD","LU0320765059.SGD","LU0820561909.HKD","LU0323591593.USD","BK4534","LU1983299246.USD","LU0058720904.USD","LU2236285917.USD","SG9999001176.USD","LU0061475181.USD","LU0823434583.USD","SG9999015945.SGD","LU1069344957.HKD","IXJ","IE00BJJMRZ35.SGD","LU2063271972.USD","LU2023251221.USD","LU2237443465.HKD","OZEM","PJP","LU0114720955.EUR","LU2462157665.USD","SG9999015952.SGD","LU0006306889.USD","BK4516","IE00BJJMRX11.SGD","LU2087625088.SGD","LU2168564495.EUR","LU0672654240.SGD","LU0353189680.USD","BK4581","IE00BK4W5L77.USD","LU2552382215.SGD","LU0882574139.USD","LU0158827781.USD","SG9999001176.SGD","LU0640476718.USD","LU0471298777.SGD","SGXZ57979304.SGD","LU0234572021.USD","SGXZ81514606.USD","LU1868837136.USD","LU1145028129.USD","LU2468319806.SGD","IE00BFTCPJ56.SGD","IE00BWXC8680.SGD","LU0345770308.USD","IE00B2B36J28.USD","LU0320765992.SGD","LU0345770993.USD","LU1548497426.USD","LU1623119135.USD","LU2271345857.HKD","LU2471134523.USD","CANC","LU0353189763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164434045","title":"美國FDA批准Inluriyo（Imlunestrant）聯合Verzenio（Abemaciclib）用於治療ER陽性、HER2陰性、ESR1突變的晚期或轉移性乳腺癌成人患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1164434045","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164434045?lang=zh_tw&edition=fundamental","pubTime":"2026-09-19 01:55","pubTimestamp":1789754137,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）已正式批准礼来公司（Eli Lilly）的Inluriyo（Imlunestrant）与Verzenio（Abemaciclib）联合用药方案，该方案适用于患有雌激素受体阳性（ER+）、人表皮生长因子受体2阴性（HER2-）且携带ESR1突变的晚期或转移性乳腺癌成人患者。这一批准标志着针对这一特定患者群体治疗选择的重要进展。值得注意的是，ESR1突变通常与内分泌治疗耐药相关，而此次获批的联合疗法或将为这类难治性患者提供新的治疗路径。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MHIP","LU2461242641.AUD","BK4533","BK4585","IE0001KFT4U8.USD","IE00BN29S564.USD","LU0198837287.USD","IE00BJJMRZ35.SGD","LU0708995401.HKD","LU1061106388.HKD","LU1868836757.USD","LU2112291526.USD","LU2237438978.USD","LU1551013342.USD","LU0006306889.USD","LU0079474960.USD","LU2023251221.USD","LU0385154629.USD","IE0004445015.USD","LU2324357040.USD","LU2750360641.GBP","BK4599","LU0943347566.SGD","LU0823416689.USD","LU2264538146.SGD","LU0432979614.USD","IE00B4R5TH58.HKD","MEDI","LLY","LU0882574055.USD","ILDR","IE00BJJMRY28.SGD","LU1629891620.HKD","LU1267930730.SGD","LU1720051017.SGD","LU2023250504.SGD","LU0109394709.USD","LU2237443549.SGD","LU0109391861.USD","LU1868837136.USD","PPH","LU0640476718.USD","LU1989771016.USD","LU2028103732.USD","LU0106261372.USD","LU0210536198.USD","LLII","LU1323610961.USD","LU2552382215.SGD","HRTS","IE00BKPKM429.USD","IE00BFSS7M15.SGD","LU1035775433.USD","IE0004445239.USD","LU2357305700.SGD","LU0417517546.SGD","IE00B1BXHZ80.USD","IXJ","BK4534","LU0094547139.USD","LU2237443978.SGD","FTXH","THNR","LU1979441026.SGD","LU2023250330.USD","LLYX","LU1127390331.HKD","SGXZ31699556.SGD","SGXZ99366536.SGD","LU0786609619.USD","LU1023059063.AUD","LU1720051108.HKD","IE00BK4W5L77.USD","LU2746668974.SGD","SG9999013999.USD","LU2552382132.HKD","IE00BWXC8680.SGD","LU0964807845.USD","IE00BJJMRX11.SGD","LU0234572021.USD","LU0320765992.SGD","LU0672654240.SGD","LU2237443465.HKD","LU1232071149.USD","LU2237443382.USD","LU2756315318.SGD","GB00BDT5M118.USD","IE00BK4W5M84.HKD","ELIL","LU0256863811.USD","TMED","LU2456880835.USD","LU1868836914.USD","LU2462157665.USD","LU1064131342.USD","LU2750360997.AUD","SG9999014898.SGD","FHLC","LU0203201768.USD","IE00B7KXQ091.USD","LU0353189763.USD","MEDX","JDOC","LU1814569148.SGD","LU2271345857.HKD","BK4516","LU2211815571.USD","LU2602419157.SGD","LU2361044865.SGD","SGXZ57979304.SGD","LU1057294990.SGD","SG9999014880.SGD","CANC","LU2168564222.USD","LU0823434740.USD","LU0683600562.USD","LU2746668461.USD","LU1623119135.USD","LU0225283273.USD","LU2106854487.HKD","LLYZ","LU0061475181.USD","BK4007","LU0354030438.USD","SG9999015952.SGD","LU0820561909.HKD","LU0456855351.SGD","LU0820561818.USD","IE0005OL40V9.USD","LU0345770993.USD","LU2756315664.SGD","PJP","LU2491049909.HKD","IE00B1XK9C88.USD","SG9999015986.USD","LU2265009873.SGD","IE00BFTCPJ56.SGD","OZEM","LU0114720955.EUR","SG9999018857.SGD","LU0174119429.USD","LU2471134879.HKD","RXL","SG9999018865.SGD","LU2168564065.EUR","LU0256863902.USD","LU2108987350.USD","LU2552382058.USD","LU0316494557.USD","LU2168564149.EUR","IE00B2B36J28.USD","LU2237443622.USD","SG9999014914.USD","LU2111349929.HKD","LU0353189680.USD","LU0889565916.HKD","LU2168563687.JPY","IHE","LU1551013425.SGD","LU2471134952.CNY","LU0882574139.USD","LU1712237335.SGD","LU2089283258.USD","IE00BJLML261.HKD","LU2236285917.USD","CURE","BK4581","LU2360106947.USD","TRUH","LU1093756168.USD","LU2468319806.SGD","LU2168564495.EUR","AGNG","LU0320765059.SGD","IYH","IE00B775H168.HKD","IE00BFSS8Q28.SGD","LU1804176565.USD","LU0289739699.SGD","LU2471134523.USD","SG9999015945.SGD","LU0323591593.USD","SG9999014906.USD","SG9999017495.SGD","LU0466842654.USD","IE00B4JS1V06.HKD","LU1548497426.USD","LU1988902786.USD","LU2361044949.HKD","XLV","LU0823434583.USD","LU2491050071.SGD","LU2462591350.SGD","LU1983299246.USD","SG9999001176.SGD","LU0471298694.HKD","SGXZ81514606.USD","BK4588","ELIS","LU2361045086.USD","IE0002141913.USD","LU2491050154.USD","LU1868837300.USD","LU0266013472.USD","LU2237443895.HKD","LU0158827781.USD","VHT","LU1069344957.HKD","LU0238689110.USD","LU0345770308.USD","LU2063271972.USD","LU2089284900.SGD","WDNA","IE00BKDWB100.SGD","LU0471298777.SGD","IE0009355771.USD","LU2417539215.USD","LU0122379950.USD","LU0097036916.USD","LU1868836591.USD","LU0096364046.USD","LU0058720904.USD","LU0133085943.USD","LU1280957306.USD","LU1917777945.USD","LU2087625088.SGD","LU0203202063.USD","LU0787776722.HKD","LU2471134796.USD","SGXZ51526630.SGD","GDOC","LU2213496289.HKD","IE00BJT1NW94.SGD","LU1093756325.SGD","LU1974910355.USD","SG9999001176.USD","LU0158827948.USD","LU0689472784.USD","LU1145028129.USD","SG9999015978.USD","LU0820562030.AUD","LU2089984988.USD","LU1366192091.USD","LU1691799644.USD","LU2896262040.SGD","LU0354030511.USD","LU1291159041.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668492808","title":"羅氏（RHHBY）重磅藥Ocrevus獲CHMP積極意見 擬在歐洲拓展兒科多發性硬化症適應症","url":"https://stock-news.laohu8.com/highlight/detail?id=2668492808","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668492808?lang=zh_tw&edition=fundamental","pubTime":"2026-09-18 19:30","pubTimestamp":1789731015,"startTime":"0","endTime":"0","summary":"金吾财讯 | 罗氏 获得欧洲药品管理局人用药品委员会积极审查意见，建议批准其旗下的抗CD20单克隆抗体药物Ocrevus，用于治疗10岁及以上儿童和青少年的复发型多发性硬化症。据介绍，继美国FDA于2026年5月批准该适应症后，若欧盟顺利获批，Ocrevus将成为欧洲首个面向10岁及以上儿科患者的高效抗CD20疗法，进一步巩固罗氏在神经科学及多发性硬化症治疗领域的市场领先地位。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250107/MWRmODAzMDJiNzRkNTY3ODIxNTExMzM=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/MWRmODAzMDJiNzRkNTY3ODIxNTExMzM=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"306226","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03165","CHMP","BK4007","HRTS","BK4087","RHHBY","CANC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CANC\",params:#limit:6,delay:false,,,undefined,":[]}}